Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Cardiovascular Effects of Parathyroid Hormone Analogues in Chronic Hypoparathyroidism

A legfontosabb adatok

Ki végzi
National and Kapodistrian University of Athens
Hol
Görögország2 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
210 fő, tervezett
Kezdés
2026. ápr. 1.
Várható befejezés
2028. dec. 31.
A vizsgálat típusa
Megfigyeléses, 4 csoport
A vizsgált kezelések
  • Arterial stiffness in the aorta by measurement of pulse wave velocity
  • Central blood pressures and reflected waves in the aorta
  • Carotid and femoral intima-media thickness (IMT) and number of carotid or femoral plaques
  • Imaging of the sublingual microcirculation (GlycoCheck system)
  • Ankle-brachial index (ABI)
  • Fundoscopy
  • Cardiac Ultrasonography Study
  • Local shear stress in brachial and carotid artery
  • Peripheral and aortic office and ambulatory blood pressure
  • Circulating levels of myocardial biomarkers
  • Evaluation of Calcium metabolism
A regiszteradat frissítve
2026. július 16.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 6 feltétel megnézéseKevesebb

Ki vehet részt

  • Cross sectional arm: Baseline State: Adults (≥18y) with chronic HypoPT (≥12 months) currently treated with conventional therapy or palopegteriparatide for more than one year; -Prospective Follow-up: Adults (≥18y) with chronic HypoPT (≥12 months) currently treated with conventional therapy and about to start treatment with palopegteriparatide willing to undergo baseline measurements (prior to the first dose) and repeat measurements at 3 and 12 months

Ki nem vehet részt

  • Bone Health: Any metabolic bone disease other than hypoparathyroidism (excluding osteoporosis)
  • Renal Function: CKD Stage 3 or higher (eGFR < 60 mL/min/1.73 m²)
  • Uncontrolled Risk Factors:; SBP > 180/100 mmHg; Uncontrolled endocrine diseases (e.g., hyper- or hypothyroidism, diabetes mellitus type 2 with HbA1c>7.5%)
  • Documented Atrial Fibrillation (ECG)
  • Contraindication to long acting PTH analogue as per product labeling

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this study is to evaluate cardiovascular effects of long-acting parathyroid hormone (PTH) analogues in adults with chronic hypoparathyroidism. The main questions it aims to answer are:

A teljes eredeti leírásKevesebb

* Do patients with hypoparathyroidism have increased arterial stiffness and markers of subclinical cardiovascular injury compared to healthy individuals? * Does treatment with a long-acting PTH analogue improve vascular and cardiac function over time compared to conventional therapy? This is a multi-center study with two parts: a cross-sectional comparison and a 12-month prospective follow-up. Adults with chronic hypoparathyroidism and matched healthy controls will undergo clinical evaluation, vascular measurements, cardiac imaging, and blood tests.

In the prospective part, patients that just started long-acting PTH analogue therapy based on their treating physicians choice will be followed for 12 months, with repeat assessments at baseline, 3 months, and 12 months to evaluate changes in cardiovascular markers.

A vizsgálat 4 csoportja

  • Patients with chronic hypoparathyroidism under conventional treatment (disease control)

    20-30 Hypo-PT patients aged ≥18 on conventional HypoPT therapy with any dose of activated vitamin D and calcium and native vitamin D supplements for at least 12 months

    Kezelés: Arterial stiffness in the aorta by measurement of pulse wave velocity, Central blood pressures and reflected waves in the aorta, Carotid and femoral intima-media thickness (IMT) and number of carotid or femoral plaques, Imaging of the sublingual microcirculation (GlycoCheck system), Ankle-brachial index (ABI), Fundoscopy, Cardiac Ultrasonography Study, Local shear stress in brachial and carotid artery, Peripheral and aortic office and ambulatory blood pressure, Circulating levels of myocardial biomarkers és Evaluation of Calcium metabolism

  • Patients with chronic hypoparathyroidism under treatment with palopegteriparatide

    40-50 Hypo-PT patients aged ≥18 treated with Palopegteriparatide (TransCon PTH) for at least 12 months

    Kezelés: Arterial stiffness in the aorta by measurement of pulse wave velocity, Central blood pressures and reflected waves in the aorta, Carotid and femoral intima-media thickness (IMT) and number of carotid or femoral plaques, Imaging of the sublingual microcirculation (GlycoCheck system), Ankle-brachial index (ABI), Fundoscopy, Cardiac Ultrasonography Study, Local shear stress in brachial and carotid artery, Peripheral and aortic office and ambulatory blood pressure, Circulating levels of myocardial biomarkers és Evaluation of Calcium metabolism

  • Healthy controls

    Healthy controls: 170 Healthy controls matched with group 1 and group 2 for age, sex, CVD presence, propensity score, DM2, renal function, BMI and SBP, retrospectively recruited from the Athens Angiometabolic Cohort

    Kezelés: Arterial stiffness in the aorta by measurement of pulse wave velocity, Central blood pressures and reflected waves in the aorta, Carotid and femoral intima-media thickness (IMT) and number of carotid or femoral plaques, Imaging of the sublingual microcirculation (GlycoCheck system), Ankle-brachial index (ABI), Fundoscopy, Cardiac Ultrasonography Study, Local shear stress in brachial and carotid artery, Peripheral and aortic office and ambulatory blood pressure, Circulating levels of myocardial biomarkers és Evaluation of Calcium metabolism

  • Patients with chronic hypoparathyroidism switching from conventional therapy to palopegteriparatide

    20 patients starting treatment with palopegteriparatide, previously on conventional treatment

    Kezelés: Arterial stiffness in the aorta by measurement of pulse wave velocity, Central blood pressures and reflected waves in the aorta, Carotid and femoral intima-media thickness (IMT) and number of carotid or femoral plaques, Imaging of the sublingual microcirculation (GlycoCheck system), Ankle-brachial index (ABI), Fundoscopy, Cardiac Ultrasonography Study, Local shear stress in brachial and carotid artery, Peripheral and aortic office and ambulatory blood pressure, Circulating levels of myocardial biomarkers és Evaluation of Calcium metabolism

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Effect of Long-acting PTH Analogues on Markers of Subclinical Arterial and Myocardial Injury in Chronic Hypoparathyroidism..
A regiszteradat frissítve
2026. július 16.